Institute of Medicine of the National Academies Report State of Cancer Care U.S.

September 13, 2013 — The Institute of Medicine (IOM) of the National Academies issued its report, “Delivering High-Quality Cancer Care: Charting a News Course for a System in Crisis.” The 315-page report, produced by a 17-member committee of cancer care leaders, concludes that the nation’s “cancer care delivery system is in crisis. Care is not patient-centered, many patients do not receive palliative care to manage their symptoms and side effects from treatment, and decisions about care often are not based on the latest scientific evidence.” In addition, the report details a six-part framework for improving the quality of cancer care, improving “the quality of life and outcomes for people facing a cancer diagnosis.”

This IOM report was sponsored by the American Society for Radiation Oncology (ASTRO) along with AARP, the American Cancer Society, the American College of Surgeons’ Commission on Cancer, the American Society of Clinical Oncology, the American Society of Hematology, the California Healthcare Foundation, the Centers for Disease Control and Prevention, LIVESTRONG, the National Cancer Institute of the National Institutes of Health, the National Coalition for Cancer Survivorship, the Oncology Nursing Society, and Susan G. Komen for the Cure. ASTRO’s Clinical Affairs and Quality Committee Chair James A. Hayman, M.D., served on the IOM committee that authored the report.

The Institute of Medicine serves as adviser to the nation to improve health. Established in 1970 under the charter of the National Academy of Sciences, the Institute of Medicine provides independent, objective, evidence-based advice to policy makers, health professionals, the private sector and the public.

For more information: www.astro.org


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Radiology Business

July 3, 2024 — The American Society of Radiologic Technologists has launched the BeRAD Professionalism Award to ...

Time July 03, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Radiation Oncology

June 3, 2024 — The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details ...

Time June 03, 2024
arrow
News | Oncology Information Management Systems (OIMS)

May 30, 2024 — RaySearch Laboratories AB announced the release of the latest version of RayCare, the next generation ...

Time May 30, 2024
arrow
Subscribe Now